Phage Engineering for Targeted Multidrug-Resistant Escherichia coli

The lytic bacteriophages have potential application value in the treatment of bacterial infections. However, the narrow host spectrum of these phages limits their range of clinical application. Here, we demonstrate the use of scarless Cas9-assisted recombination (no-SCAR) gene-editing technology to...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jiaoyang, Liu, Zhengjie, Zhang, Qing, Liu, Yuqing, Chen, Yibao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004113/
https://www.ncbi.nlm.nih.gov/pubmed/36768781
http://dx.doi.org/10.3390/ijms24032459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004113/
https://www.ncbi.nlm.nih.gov/pubmed/36768781
http://dx.doi.org/10.3390/ijms24032459

Ejemplares similares